Evidence map›Paper›PMID 37289937›Full record

ArticleAnalytical chemistry2023

High-Throughput Single-Cell Proteomic Analysis of Organ-Derived Heterogeneous Cell Populations by Nanoflow Dual-Trap Single-Column Liquid Chromatography.

Simion Kreimer, Aleksandra Binek, Blandine Chazarin, Jae Hyung Cho, Ali Haghani, Alexandre Hutton, Eduardo Marbán, Mitra Mastali, Jesse G Meyer, Thassio Mesquita and 3 more

Abstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Proteomic Characterization of Bottlenose Dolphin (Journal of proteome research · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. SynchroSep-MS: Parallel LC Separations for Multiplexed Proteomics.Journal of the American Society for Mass Spectrometry · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Simion KreimerAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0001-6627-3771
Aleksandra BinekAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Blandine ChazarinAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Jae Hyung ChoSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0002-3851-2947
Ali HaghaniAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Alexandre HuttonAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Eduardo MarbánSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Mitra MastaliAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Jesse G MeyerAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0003-2753-3926
Thassio MesquitaSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0002-6927-5745
Yang SongAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Jennifer Van EykAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0001-9050-148X
Sarah ParkerAdvanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.ORCID 0000-0001-8911-3615

Funding

Democratizing Multi-Omics to Expedite Discovery of Hidden Metabolic PathwaysR35GM142502 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI MEYER, JESSE · 2021 to 2025
$2.2M
Mechanisms of sex-biased risk and resiliency in aneurysm and dissectionR01HL165471 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI PARKER, SARAH J · 2022 to 2025
$1.7M
NHLBI NIH HHS R01 HL165471NIGMS NIH HHS R35 GM142502
6 · The paper itself

Abstract

Identification and proteomic characterization of rare cell types within complex organ-derived cell mixtures is best accomplished by label-free quantitative mass spectrometry. High throughput is required to rapidly survey hundreds to thousands of individual cells to adequately represent rare populations. Here we present parallelized nanoflow dual-trap single-column liquid chromatography (nanoDTSC) operating at 15 min of total run time per cell with peptides quantified over 11.5 min using standard commercial components, thus offering an accessible and efficient LC solution to analyze 96 single cells per day. At this throughput, nanoDTSC quantified over 1000 proteins in individual cardiomyocytes and heterogeneous populations of single cells from the aorta.

Indexed as

ProteinsProteomicsChromatography, LiquidMass SpectrometryPeptidesPeptidesProteins

Identifiers

PMID37289937
PMCPMC11141483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.